Monitoring tolerance after human liver transplantation

Transplant Immunology

Volumn 17, Issue 2, 2007, Pages 83-93

  Wieërs, Grégoire ^a   Gras, Jérémie ^a   Bourdeaux, Christophe ^a   Truong, Dinh Quang ^a   Latinne, Dominique ^a   Reding, Raymond ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Human; Liver; Monitoring; Review; Tolerance; Transplantation

Indexed keywords

ALPHA INTERFERON; CALCINEURIN INHIBITOR; CD24 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; GENETIC POLYMORPHISM; GENOTYPE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOLOGICAL MONITORING; IMMUNOLOGICAL TOLERANCE; IMMUNOPROPHYLAXIS; IN VITRO STUDY; IN VIVO STUDY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROCHIMERISM; MOLECULAR IMAGING; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; REVIEW; RNA ANALYSIS; TH1 CELL; TH2 CELL; TH3 CELL; TRANSPLANTATION TOLERANCE;

CLONAL DELETION; CYTOKINES; DENDRITIC CELLS; DIAGNOSTIC IMAGING; LIVER TRANSPLANTATION; MONITORING, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 33846904119     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.09.020     Document Type: Review

References (103)

1. van Twuyver E., de Hoop J., ten Berge R.J.M., et al. Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world. Transplantation 61 (1996) 1392-1397
2. Ashton-Chess J., Brouard S., and Soulillou J.P. Is clinical tolerance realistic in the next decade?. Transpl Int 19 (2006) 539-548
3. Eason J.D., Cohen A.J., Nair S., Alcantera T., and Loss G.E. Tolerance: is it worth the risk?. Transplantation 79 (2005) 1157-1159
4. Kirk A.D. Meteorology and tolerance. Am J Transplant 6 (2006) 645-646
5. Newell K.A., Larsen C.P., and Kirk A.D. Transplant tolerance: converging to a moving target. Transplantation 81 (2006) 1-6
6. Reding R., Gras J., Quang Truong D., Wieërs G., and Latinne D. The immunological monitoring of alloreactive responses in liver transplant recipients: a review. Liver Transpl 12 (2006) 373-383
7. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature 172 (1953) 603-606
8. Salama A.D., Remuzzi G., Harmon W.E., and Sayegh M.H. Challenges to achieving clinical transplantation tolerance. J Clin Invest 108 (2001) 943-948
9. Ansari M.J.I., and Sayegh M.H. Clinical transplantation tolerance: the promise and challenges. Kidney Int 65 (2004) 1560-1563
10. Calne R.Y., Friend P., Moffatt S., et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351 (1998) 1701-1702
11. Calne R.Y. Prope tolerance - the future of organ transplantation from the laboratory to the clinic. Transpl Immunol 13 (2004) 83-86
12. Cortesini R., and Suciu-Foca N. The concept of "partial" clinical tolerance. Transpl Immunol 13 (2004) 101-104
13. Tinckam K.J., and Sayegh M.H. Transplantation tolerance in pediatric recipients: lessons and challenges. Pediatr Transpl 9 (2005) 17-27
14. Witowski J., Ksiazek K., and Jörres A. Interleukin-17: a mediator of inflammatory response. CMLS 61 (2004) 567-579
15. Woltman A., Haij S., Boonstra J., Gobin S., Daha M., and Kooten C. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 11 (2000) 2044-2055
16. Antonysamy A., Fanslow W., Li F., Qian S., and Thomson A. Evidence for a role of IL17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival. Transplant Proc 31 (1999) 93
17. Strom T.B., Roy-Chaudhury P., Manfro R., et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8 (1996) 688-693
18. Mele T.S., Kneteman N.M., Zhu L.F., et al. IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant 3 (2003) 942-951
19. Elwood E.T., Larsen C.P., Maurer D.H., et al. Microchimerism and rejection in clinical transplantation. Lancet 349 (1997) 1358-1360
20. Rokahr K.L., Sharland A.F., Sun J., et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 95 (1998) 257-263
21. Holzknecht Z.E., and Platt J.L. The fine cytokine line between graft acceptance and rejection. Nat Med 6 (2000) 497-498
22. Pirenne J., Kitade H., Kawai M., et al. Regulatory cells, Th1/Th2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 79 (2005) S25-S27
23. Mazariegos G.V., Reyes J., Webber S.A., et al. Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 73 (2003) 1342-1345
24. Keen L.J. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 10 (2005) 143-146
25. Warlé M.C., Metselaar H.J., Hop W.C.J., and Tilanus H.W. Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis. Liver Transpl 11 (2005) 19-26
26. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
27. Thomson A.W., Mazariegos G.V., Reyes J., et al. Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 72 (2001) S13-S22
28. Marin L.A., Muro M., Moya-Quiles M.R., et al. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients. Tissue Antigens 67 (2006) 117-126
29. Asakura T., Ohkohchi N., and Satomi S. Changes of serum cytokines with hepatic regeneration after living-related liver transplantation. Transplant Proc 32 (2000) 2199-2203
30. Cookson S., Doherty D.G., Todryk S., et al. Hepatic expression of IL-15 mRNA is associated with liver graft acceptance. Transpl Immunol 11 (2003) 39-48
31. Conti F., Frappier J., Dharancy S., et al. Interleukin-15 production during liver allograft rejection in humans. Transplantation (2003) 210-216
32. Conti F., Calmus Y., Rouer E., et al. Increased expression of interleukin-4 during liver allograft rejection. J Hepatol 30 (1999) 935-943
33. Kita Y., Iwaki Y., Noguchi K., et al. Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc 28 (1996) 1229-1234
34. Sankary H., Chong A., Frye E., et al. Daily determinations of serum lymphotoxin allows for accurate early diagnosis of hepatic allograft rejection. Transplant Proc 25 (1993) 928-930
35. Le Moine O., Marchant A., Durand F., et al. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 20 (1994) 889-892
36. Park H., Li Z., Yang X., et al. A distinct lineage of CD4 T cells regulate tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1140
37. Hayashi M., Martinez O.M., Garcia-Kennedy R., So S., Esquivel C.O., and Krams S.M. Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60 (1995) 1533-1538
38. Gorczynski R.M., Adams R.B., Levy G.A., and Chung S.W. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery 120 (1996) 496-502
39. Zhou L., Toungouz M., Donckier V., et al. A rapid test to monitor alloreactive responses in whole blood using real-time polymerase chain reaction. Transplantation 80 (2005) 410-413
40. Coates P.T.H., and Thomson A.W. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant 2 (2002) 299-307
41. Mazariegos G., Zahorchak A.F., Reyes J., Chapman H., Zeevi A., and Thomson A.W. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5 (2005) 314-322
42. Mazariegos G.V., Zahorchak A.F., Reyes J., et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3 (2003) 689-696
43. Chan C., Lechler R.I., and George A.J.T. Tolerance mechanisms and recent progress. Transplant Proc 36 (2004) 561S-569S
44. Sharabi Y., and Sachs D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169 (1989) 493-502
45. Sachs D.H. Mixed chimerism as an approach to transplantation tolerance. Clin Immunol 95 (2000) S63-S68
46. Donckier V., Toungouz M., and Goldman M. Transplantation tolerance and mixed chimerism: at the frontier of clinical application. Transpl Int 14 (2001) 1-5
47. Tryphonopoulos P., Tzakis A.G., Weppler D., et al. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant 5 (2005) 608-613
48. Sharland A., Yan Y., Wang C., et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 68 (1999) 1736-1745
49. Starzl T.E., Demetris A.J., Murase N., Ildstad S., Ricordi C., and Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 339 (1992) 1579-1582
50. Starzl T.E., and Zinkernagel R.M. Antigen localization and migration in immunity and tolerance. N Engl J Med 339 (1998) 1905-1913
51. Strober S., Benike C., Krishnaswamy S., Engleman E.G., and Grumet F.C. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation 69 (2000) 1549-1554
52. Wood K.J. Passenger leukocytes and microchimerism: what role in tolerance induction?. Transplantation 75 (2003) 17S-20S
53. Norris S., Lawler M., McCann S., Hegarty J., and O'Farrelly C. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance. Hepatology 26 (1997) 848-852
54. Schlitt H.J., Hundrieser J., Ringe B., and Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 330 (1994) 646-647
55. Bettens F., Tiercy J.M., Campanile N., et al. Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transpl 11 (2005) 290-297
56. Koopmans M., Kremer Hovinga I.C.L., Baelde H.J., et al. Chimerism in kidneys, livers and hearts of normal women: implications for transplantation studies. Am J Transplant 5 (2005) 1495-1502
57. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
58. Bolton E.M. Regulatory T cells in transplantation: natural or induced?. Transplantation 79 (2005) 643-645
59. Oluwole S.F., Oluwole O.O., Depaz H.A., Adeyeri A.O., Witkowski P., and Hardy M.A. CD4+ CD25+ regulatory T cells mediate acquired transplant tolerance. Transpl Immunol 11 (2003) 287-293
60. Salama A.D., Najafian N., Clarkson M.R., Harmon W.E., and Sayegh M.H. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14 (2003) 1643-1651
61. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 6 (2005) 338-344
62. Hong J., and Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 114 (2004) 1198-1208
63. Lan Y.R., Ansari A.A., Zhe-Xiong L., and Gershwin M.E. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 4 (2005) 351-363
64. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 176 (2006) 2790-2798
65. Liu J., Liu Z., Witkowski P., et al. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 13 (2004) 239-247
66. Zhu-Xu Z., Stanford W.L., and Li Z. Ly-6A is critical for the function of double negative regulatory T cells. Eur J Immunol 32 (2002) 1584-1592
67. Koh H., Faunce E., Taniguchi A., Falk S., and Sein-Streilein J. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. Am Ass Immunol 166 (2001) 42-50
68. Wood K.J., Luo S., and Akl A. Regulatory T cells: potential in organ transplantation. Transplantation 77 (2004) S6-S8
69. Waldmann H., and Cobbold S. Regulating the immune response to transplants: a role for CD4+ regulatory cells?. Immunity 14 (2001) 399-406
70. Game D.S., Hernandez-Fuentes M.P., and Lechler R.I. Everolimus and basiliximab permit suppression by human CD4+ CD25+ cells in vitro. Am J Transplant 5 (2005) 454-464
71. Dahmen U., Qian S., Rao A.S., et al. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 58 (1994) 1-8
72. Takatsuki M., Uemoto S., Inomata Y., et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72 (2001) 449-454
73. Li Y., Koshiba T., Yoshizawa A., et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4 (2004) 2118-2125
74. Young K.J., Yang L., Phillips M.J., and Zhang L. Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100 (2002) 3408-3414
75. + regulatory cells. J Immunol 167 (2001) 107-113
76. Kitade H., Kawai M., Koshiba T., et al. Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy?. Transplantation 78 (2004) 1747-1755
77. Chung S.W., Yoshida E.M., Cattral M.S., Hu Y., and Gorczynski R.M. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett 63 (1998) 91-96
78. Tkaczuk J., Rostaing L., Puyoo O., et al. Flow cytometry detection of intracytoplasmic cytokines after neoral or sirolimus intake is an informative tool for monitoring in vivo immunosuppressive efficacy in renal transplant recipients. Transplant Proc 30 (1998) 2400-2401
79. van den Berg A.P., Twilhaar W.N., Mesander G., et al. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production. Transplantation 65 (1998) 1066-1071
80. Magee C.C., Denton M.D., Womer K.L., Khoury S.J., and Sayegh M.H. Assessment of flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients. Clin Transplant 18 (2004) 395-401
81. Augustine J.J., Siu D.S., Clemente M.J., Schulak J.A., Heeger P.S., and Hricik D.E. Pre-transplant IFN-γ ELISPOTs are associated with post-transplant renal function in African American renal transplant patients. Am J Transplant 5 (2005) 1971-1975
82. Nickel P., Presber F., Bold G., et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 78 (2004) 1640-1646
83. van Besouw N.M., Zuijderwijk J.M., de Kuiper P., Ijzermans J.N., Weimar W., and van der Mast B.J. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 79 (2005) 1062-1066
84. Hricik D.E., Rodriguez V., Riley J., et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 3 (2003) 878-884
85. Gebauer B.S., Hricik D.E., Atallah A., et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2 (2002) 857-866
86. Najafian N., Salama A.D., Fedoseyeva E.V., Benichou G., and Sayegh M.H. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13 (2002) 252-259
87. Weston S.J., Leistikow R.L., Reddy K.R., et al. Reconstitution of hepatitis C virus-specific T-cell mediated immunity after liver transplantation. Hepatology 41 (2005) 72-81
88. Smets F., Latinne D., Bazin H., et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of post-transplant lymphoproliferative disease. Transplantation 73 (2002) 1603-1610
89. Carrodeguas L., Orosz C.G., Waldman W.J., Sedmak D.D., Adams P.W., and VanBuskirk A.M. Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol 60 (1999) 640-651
90. VanBuskirk A.M., Burlingham W.J., Jankowska-Gan E., et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 106 (2000) 145-155
91. Rodriguez D.S., Jankowska-Gan E., Haynes L.D., et al. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant 4 (2004) 537-543
92. Jankowska-Gan E., Rhein T., Haynes L.D., et al. Human liver allograft acceptance and the "tolerance assay". II. Donor HLA-A,-B but not-DR antigens are able to trigger regulation of DTH. Hum Immunol 63 (2002) 862-870
93. Kabelitz D. Apoptosis, graft rejection, and transplantation tolerance. Transplantation 65 (1998) 869-875
94. Bohnenkamp H.R., Burchell J.M., Taylor-Papadimitriou J., and Noll T. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. J Immunol Methods 294 (2004) 67-80
95. Qian S., Lu L., Fu F., et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 158 (1997) 4654-4661
96. Sharland A., Shastry S., Wang C., et al. Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: Early activation and apoptosis is associated with liver graft acceptance. Transplantation 65 (1998) 1370-1377
97. Douillard P., Cuturi M.C., Brouard S., Josien R., and Soulillou J.P. T cell receptor repertoire usage in allotransplantation: an overview. Transplantation 68 (1999) 913-921
98. Guillet M., Brouard S., Gagne K., et al. Different qualitative and quantitative regulation of V-beta TCR transcripts during early acute allograft rejection and tolerance induction. J Immunol 168 (2002) 5088-5095
99. Alvarez C.M., Opelz G., Giraldo M.C., et al. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant 5 (2005) 746-756
100. Brouard S., Dupont A., Giral M., et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 5 (2005) 330-340
101. Kanderi T., Moore W.H., and Wendt J.A. Molecular imaging in transplantation: basic concepts and strategies for potential application. Nucl Med Commun 26 (2005) 947-955
102. Ho C., and Hitchens T.K. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Curr Pharm Biotechnol 5 (2004) 551-566
103. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 (2001) 316-333